Prim, S.A. (BME:PRM)
Spain · Delayed Price · Currency is EUR 13.20
0.00 (0.00%)
At close: Dec 24, 2025
Prim, S.A. Market Cap
Prim, S.A. has a market cap or net worth of €224.61 million as of December 26, 2025. Its market cap has increased by 32.26% in one year.
Market Cap
224.61M
Enterprise Value
228.24M
Revenue
240.68M
Ranking
n/a
PE Ratio
15.53
Stock Price
€13.20
Market Cap Chart
Since March 2, 1998, Prim, S.A.'s market cap has increased from 7.51M to 224.61M, an increase of 2,892.30%. That is a compound annual growth rate of 12.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 224.61M | 37.21% |
| Dec 31, 2024 | 163.70M | -7.91% |
| Dec 29, 2023 | 177.76M | -3.62% |
| Dec 30, 2022 | 184.45M | -26.55% |
| Dec 30, 2021 | 251.13M | 49.42% |
| Dec 31, 2020 | 168.06M | -15.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.68B |
| Laboratorios Farmaceuticos Rovi | 3.21B |
| Almirall | 2.75B |
| Faes Farma | 1.62B |
| Pharma Mar | 1.32B |
| Clínica Baviera | 763.78M |
| Oryzon Genomics | 250.75M |
| Laboratorio Reig Jofre | 209.99M |